loadpatents
name:-0.023674011230469
name:-0.0075318813323975
name:-0.0006258487701416
Bolt; Gert Patent Filings

Bolt; Gert

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bolt; Gert.The latest application filed is for "compounds suitable for treatment of haemophilia".

Company Profile
0.8.22
  • Bolt; Gert - Vaerloese DK
  • Bolt; Gert - Vaerlose N/A DK
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compounds Suitable for Treatment of Haemophilia
App 20180179262 - Bolt; Gert ;   et al.
2018-06-28
Factor VIII polypeptide titers in cell cultures
Grant 9,982,033 - Johnsen , et al. May 29, 2
2018-05-29
Factor VIII Molecules with Reduced VWF Binding
App 20170020992 - Bolt; Gert ;   et al.
2017-01-26
Factor VIII Fusion Protein
App 20170015729 - Bolt; Gert ;   et al.
2017-01-19
Factor VIII fusion protein
Grant 9,493,543 - Bolt , et al. November 15, 2
2016-11-15
Compounds Suitable for Treatment of Haemophilia
App 20160318991 - Bolt; Gert ;   et al.
2016-11-03
Conjugated Factor VIII Molecules
App 20160222086 - Bolt; Gert ;   et al.
2016-08-04
Compounds Suitable for Treatment of Haemophilia
App 20160207977 - Olsen; Ole Hvilsted ;   et al.
2016-07-21
Pharmaceutical Composition Suitable for Treatment of Haemophilia
App 20160120954 - Bolt; Gert ;   et al.
2016-05-05
Conjugated factor VIII molecules
Grant 9,150,848 - Bolt , et al. October 6, 2
2015-10-06
Compounds suitable for treatment of haemophilia
Grant 9,125,890 - Bolt , et al. September 8, 2
2015-09-08
Compounds Suitable for Treatment of Haemophilia
App 20150080309 - Bolt; Gert ;   et al.
2015-03-19
Pharmaceutical Composition Suitable for Treatment of Haemophilia
App 20150045303 - Bolt; Gert ;   et al.
2015-02-12
Hyperglycosylated human coagulation factor IX
Grant 8,871,714 - Bolt , et al. October 28, 2
2014-10-28
Conjugated Factor Viii Molecules
App 20140242057 - Bolt; Gert ;   et al.
2014-08-28
Compounds Suitable For Treatment Of Haemophilia
App 20140018297 - Bolt; Gert ;   et al.
2014-01-16
Conjugated factor VIII molecules
Grant 8,536,126 - Bolt , et al. September 17, 2
2013-09-17
Conjugated Factor VIII Molecules
App 20130189239 - Bolt; Gert ;   et al.
2013-07-25
Conjugated Factor Viii Molecules
App 20130137638 - Bolt; Gert ;   et al.
2013-05-30
Hyperglycosylated Human Coagulation Factor IX
App 20130095555 - Bolt; Gert ;   et al.
2013-04-18
Factor VIII Fusion Protein
App 20130040889 - Bolt; Gert ;   et al.
2013-02-14
Hyperglycosylated Human Coagulation Factor Ix
App 20110137011 - Bolt; Gert ;   et al.
2011-06-09
N-glycosylated Human Growth Hormone With Prolonged Circulatory Half-life
App 20110118183 - Bolt; Gert ;   et al.
2011-05-19
Factor Viii Polypeptide Titers In Cell Cultures
App 20100120094 - Johnsen; Laust Bruun ;   et al.
2010-05-13
Blood Coagulation FVIII Analogues
App 20080227691 - Ostergaard; Henrik ;   et al.
2008-09-18
Glycosylation-Disrupted Factor VII Variants
App 20080058255 - Bolt; Gert ;   et al.
2008-03-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed